Bharat Biotech to soon start Covaxin manufacturing facility in Bengaluru
Jun 30, 2021
By Shalini Bhardwaj And Sahil Pandey
New Delhi [India], June 30 : Hyderabad-based manufacturer Bharat Biotech hopes to start manufacturing its COVID-19 vaccine Covaxin in Bengaluru soon, according to sources.
"Bharat Biotech hopes to start manufacturing of Covaxin at Bengaluru facility soon, all regulatory government approvals in place," sources told ANI on Wednesday.
The manufacturing process will likely be by the end of July or the early August.
In April, Bharat Biotech had announced expansion of its manufacturing capacity across multiple facilities in the city and Bengaluru to produce 700 million doses of COVAXIN annually.
Bharat Biotech has set a target of producing 10-12 million doses of the COVID-19 vaccine per month.
